Dual-Targeting Dual-Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual-Targeting Dual-Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity
Authors
Keywords
-
Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-04-04
DOI
10.1002/anie.201903112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance
- (2018) Emanuele Petruzzella et al. Chemical Science
- Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes
- (2018) Suxing Jin et al. INORGANIC CHEMISTRY
- Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1
- (2017) Margaret O. James et al. PHARMACOLOGY & THERAPEUTICS
- Dichloroacetate Prevents Cisplatin-Induced Nephrotoxicity without Compromising Cisplatin Anticancer Properties
- (2016) R. Galgamuwa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
- (2016) Raji Raveendran et al. Chemical Science
- Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate
- (2015) Rosa Ferriero et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Influence of reducing agents on the cytotoxic activity of platinum(iv) complexes: induction of G2/M arrest, apoptosis and oxidative stress in A2780 and cisplatin resistant A2780cis cell lines
- (2015) Verena Pichler et al. Metallomics
- Sub-nephrotoxic cisplatin sensitizes rats to acute renal failure and increases urinary excretion of fumarylacetoacetase
- (2015) Laura Vicente-Vicente et al. TOXICOLOGY LETTERS
- Mito-DCA: A Mitochondria Targeted Molecular Scaffold for Efficacious Delivery of Metabolic Modulator Dichloroacetate
- (2014) Rakesh K. Pathak et al. ACS Chemical Biology
- Detouring of cisplatin to access mitochondrial genome for overcoming resistance
- (2014) S. Marrache et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phenylbutyrate Therapy for Pyruvate Dehydrogenase Complex Deficiency and Lactic Acidosis
- (2013) R. Ferriero et al. Science Translational Medicine
- Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology
- (2013) Gopinath Sutendra et al. Frontiers in Oncology
- Overexpression of Pyruvate Dehydrogenase Kinase 1 and Lactate Dehydrogenase A in Nerve Cells Confers Resistance to Amyloid β and Other Toxins by Decreasing Mitochondrial Respiration and Reactive Oxygen Species Production
- (2012) Jordan T. Newington et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics
- (2012) S. Marrache et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines
- (2011) Wolfgang Fiebiger et al. Clinical & Translational Oncology
- HIF-1 prevents the overproduction of mitochondrial ROS after cytokine stimulation through induction of PDK-1
- (2010) Keita Kirito et al. CELL CYCLE
- Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC
- (2010) Luke H. Stockwin et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanisms of Cisplatin Nephrotoxicity
- (2010) Ronald P. Miller et al. Toxins
- Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
- (2009) Shanta Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
- (2008) E D Michelakis et al. BRITISH JOURNAL OF CANCER
- Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death
- (2008) H. Pan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now